Last Round
Series B
Jul 3, 2026
Total Funding Raised
$97.22M
Company Overview
Beijing Inflama Lab is a biotechnology company that develops revolutionary innovative drugs for the treatment of inflammation and tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
intracellular antibodyNLRP3 inhibitorantibody delivery platformantibody therapeuticsbispecific antibodyinflammatory disease therapycell-penetrating antibodiesintrabodyNLRP3 inflammasomebiologicsbiopharmadrug discoverypreclinical biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beijing Inflama Lab Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Beijing Inflama Lab Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 3, 2026 | ||||
| Series A Extension | May 24, 2024 | ||||
| Series A | Jul 10, 2023 | ||||
| Angel | Jan 1, 2021 |
Beijing Inflama Lab Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Angel, Series A |
| Beijing Chang Development | Series B, Angel, Series A |
| MSA Capital | Series A, Angel |
| China Reform Holdings Corporation Ltd. | Series B |
| China Reform Fund Management Co.,Ltd | Series B |
| 上海国投先导私募基金管理有限公司 | Series B |
| Frees Fund | Series B, Series A Extension, Angel, Series A |
Beijing Inflama Lab Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Beijing Inflama Lab's valuation, stock price, and market status.